Many controversies surround screening for developmental dysplasia of the hip (DDH). The Ortolani 1 and Barlow tests 2 are accepted as the cornerstone of DDH clinical screening, 3,4 even if there is no adequate evidence of their accuracy. The positive predictive value (PPV) of clinical hip examination could be as low as 5%, 5 and referral rates are increasing. 6,7 Previous studies have not described the differences between the Ortolani and Barlow tests in terms of their PPV. However, it is widely accepted that the Ortolani test is the most important test as it indicates when the femoral head is dislocated at rest. 3,8,9 The spontaneous resolution of clinical instability makes the diagnosis of pathological hip dysplasia difficult. Delaying the hip